Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
Charles River (CRL) Buys Explora BioLabs to Expand in CRO Space
03:48pm, Monday, 11'th Apr 2022 Zacks Investment Research
Explora BioLabs' business is likely to complement and expand the Charles River's (CRL) CRADL operation within the broader Insourcing Solutions business.
Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth
02:37pm, Monday, 11'th Apr 2022 Zacks Investment Research
In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.
STERIS (STE) Up 8% Since Q3 Earnings: What's Driving It?
02:18pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about STERIS' (STE) robust segmental growth and noteworthy acquisitions in the healthcare and pharmaceutical spaces.
Here's Why You Should Retain Charles River (CRL) Stock For Now
12:54pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about Charles River's (CRL) strong segmental growth and notable partnerships.
Henry Schein (HSIC) Hits a New 52-Week High: What's Driving It?
12:50pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about Henry Schein (HSIC) owing to favorable dental business trends and a strong solvency position.
Top 5 S&P 500 Stock Picks To Buy Now
10:00am, Monday, 11'th Apr 2022 Seeking Alpha
S&P 500 stocks offer broad exposure to the U.S. stock market and are a great way to diversify a portfolio. Click here for our top 5 S&P 500 stocks to buy now.
Top 5 S&P 500 Stock Picks To Buy Now
06:00am, Monday, 11'th Apr 2022
Investible ETFs that passively reflect the S&P 500 hold immense concentration. The top ten companies in the S&P 500 make up approximately 30% of the overall index.
McKesson: Market Is Catching On, Is This The Perfect Stock Right Now?
05:16am, Saturday, 09'th Apr 2022 Seeking Alpha
McKesson is a leader in the health care industry with moderate growth and relative immunity to economic conditions; it's still underappreciated by the market. Read more here.
McKesson: Market Is Catching On, Is This The Perfect Stock Right Now?
01:16am, Saturday, 09'th Apr 2022
McKesson is a leader in the health care industry with moderate growth and relative immunity to economic conditions; it's still underappreciated by the market.
10 Stocks That Have Moved Over 20% Since The Indices Plummeted
06:49pm, Friday, 08'th Apr 2022 Benzinga
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
The S&P fell by 14.
Zacks.com featured highlights include The Kroger, NVIDIA, Jones Lang LaSalle, Paychex and McKesson
03:01pm, Friday, 08'th Apr 2022 Zacks Investment Research
The Kroger, NVIDIA, Jones Lang LaSalle, Paychex and McKesson are part of today's Screen of the Week article.
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
02:51pm, Friday, 08'th Apr 2022
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Bet on These 4 Low-Beta, High-Dividend MedTech Stocks for 2022
11:17am, Friday, 08'th Apr 2022
Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.
Here's Why You Should Hold on to Chemed (CHE) Stock For Now
03:18pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
Here's Why You Should Retain Amedisys (AMED) Stock For Now
02:11pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Investors are optimistic about Amedisys' (AMED) strong segmental performance and strategic buyouts.
